DARUNAVIR FORMULATIONS

This invention relates to solid oral dosage forms of the HIV inhibitor darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.

Saved in:
Bibliographic Details
Main Authors DELAET, Urbain Alfons C, HEYNS, Philip Erna H, JANS, Eugeen Maria Jozef
Format Patent
LanguageEnglish
Published 12.08.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:This invention relates to solid oral dosage forms of the HIV inhibitor darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
Bibliography:Application Number: US202117242218